Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Sage

Recent news which mentions Sage

< Previous 1 2 3 4 5 6 7 8 9 Next >

Sage Therapeutics's Return On Capital Employed Insights

December 05, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022

November 01, 2022

Sage Therapeutics/Biogen Highlight Additional Data From Depression Candidate

October 17, 2022

For the 5th Time, Alta Vista Technology Appears on the Inc. 5000

August 25, 2022

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study

August 02, 2022

Sage Therapeutics: Q2 Earnings Insights

August 02, 2022

Earnings Scheduled For August 2, 2022

August 02, 2022

Alta Vista Technology Honored in Accounting Today VAR 100

July 11, 2022

Where Sage Therapeutics Stands With Analysts

July 11, 2022

Alta Vista Technology Launches Affiliate Program With Sage & Microsoft Partners

June 16, 2022

Why Shares of Sage Therapeutics Climbed 15.6% This Week

June 03, 2022

8 Analysts Have This to Say About Sage Therapeutics

May 24, 2022

1 Reason to Buy Biogen Now, and 1 Reason to Wait

May 05, 2022

Analyst Ratings for Sage Therapeutics

May 04, 2022

Beset by challenges with its Alzheimer’s disease drug, Biogen pivots

May 03, 2022

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs

May 03, 2022

Sage Therapeutics: Q1 Earnings Insights

May 03, 2022

Earnings Scheduled For May 3, 2022

May 03, 2022

Sage Therapeutics, Biogen Start Rolling Submission For Zuranolone In Major Depressive Disorder

May 02, 2022

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More

May 02, 2022

Is This Biotech Stock Worth the Trouble?

April 23, 2022

Sage Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know

April 21, 2022

The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel

April 05, 2022

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight

April 03, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

April 01, 2022

Expert Ratings For Sage Therapeutics

March 31, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022

March 31, 2022

Expert Ratings For Sage Therapeutics

February 25, 2022

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

February 24, 2022

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.